BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL

被引：0
|
作者：
Sathornsumetee, Sith [1 ]
Desjardins, Annick [1 ]
Vredenburgh, James J. [1 ]
Rich, Jeremy N. [1 ]
Gururangan, Sridharan [1 ]
Janney, D. E. [1 ]
Friedman, Allan H. [1 ]
Friedman, Henry S. [1 ]
Reardon, David A. [1 ]
机构：
[1] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：906 / 906
页数：1
相关论文
共 50 条
  • [1] VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL
    Peters, Katherine
    Reardon, David
    Randazzo, Dina
    Dutton, Shelley
    Edwards, Ashley
    Lipp, Eric
    Herndon, James, II
    McSherry, Frances
    Desjardins, Annick
    Ranjan, Tulika
    Vlahovic, Gordana
    Friedman, Henry
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [2] VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL
    Peters, Katherine B.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Coan, April
    McSherry, Frances
    Lipp, Eric
    Brickhouse, Alise
    Massey, Woody
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 81 - 81
  • [3] Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    McLendon, Roger E.
    Marcello, Jennifer
    Herndon, James E.
    Mathe, Alyssa
    Hamilton, Marta
    Rich, Jeremy N.
    Norfleet, Julie A.
    Gururangan, Sridharan
    Friedman, Henry S.
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2010, 12 (12) : 1300 - 1310
  • [4] A phase II trial of sunitinib in patients with recurrent high-grade glioma
    Chaskis, C.
    Sadones, J.
    Michotte, A.
    Dujardin, M.
    Everaert, H.
    Neyns, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II trial of temozolomide in children with recurrent high-grade glioma
    A. Ruggiero
    G. Cefalo
    M.L. Garré
    M. Massimino
    C. Colosimo
    G. Attinà
    I. Lazzareschi
    P. Maurizi
    V. Ridola
    G. Mazzarella
    M. Caldarelli
    C. Di Rocco
    E. Madon
    M.E. Abate
    A. Clerico
    A. Sandri
    R. Riccardi
    [J]. Journal of Neuro-Oncology, 2006, 77 : 89 - 94
  • [6] Phase II trial of temozolomide in children with recurrent high-grade glioma
    Ruggiero, A.
    Cefalo, G.
    Garre, M. L.
    Massimino, M.
    Colosimo, C.
    Attina, G.
    Lazzareschi, I.
    Maurizi, P.
    Ridola, V.
    Mazzarella, G.
    Caldarelli, M.
    Di Rocco, C.
    Madon, E.
    Abate, M. E.
    Clerico, A.
    Sandri, A.
    Riccardi, R.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (01) : 89 - 94
  • [7] BEVACIZUMAB AND CARBOPLATIN FOR RECURRENT HIGH-GRADE GLIOMA
    Mrugala, Maciej M.
    Lee, Laurie K.
    Graham, Carrie A.
    Fink, James R.
    Spence, Alexander M.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 55 - 55
  • [8] UPDATED RESULTS OF A PHASE II TRIAL OF BEVACIZUMAB AND IRINOTECAN IN RELAPSED HIGH-GRADE GLIOMA
    Keyrouz, V. F.
    Elias, E.
    Chahine, G. Y.
    Comair, Y. G.
    Dimassi, H.
    Kamar, F. G.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 47 - 47
  • [9] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
    Franceschi, E
    Cavallo, G
    Scopece, L
    Paioli, A
    Pession, A
    Magrini, E
    Conforti, R
    Palmerini, E
    Bartolini, S
    Rimondini, S
    Esposti, RD
    Crinó, L
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (06) : 1038 - 1044
  • [10] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
    E Franceschi
    G Cavallo
    L Scopece
    A Paioli
    A Pession
    E Magrini
    R Conforti
    E Palmerini
    S Bartolini
    S Rimondini
    R Degli Esposti
    L Crinò
    [J]. British Journal of Cancer, 2004, 91 : 1038 - 1044
12345